Abstract
Background
Systemic inflammatory response is significant prognostic indicator in patients with various diseases. The relationship between prognostic scoring systems based on the modified Glasgow Prognostic Score (mGPS) and achalasia in patients treated with laparoscopic Heller‑myotomy with Dor‑fundoplication (LHD) remains uninvestigated. This study aimed to examine the role of mGPS in patients with achalasia.
Methods
457 patients with achalasia who underwent LHD as the primary surgery between September 2005 and December 2020 were included. We divided patients into the mGPS 0 and mGPS 1 or 2 groups and compared the patients’ background, pathophysiology, symptoms, surgical outcomes, and postoperative course.
Results
mGPS was 0 in 379 patients and 1 or 2 in 78 patients. Preoperative vomiting and pneumonia were more common in patients with mGPS of 1 or 2. There were no differences in surgical outcomes. Postoperative upper gastrointestinal endoscopy revealed that severe esophagitis was more frequently observed in patients with mGPS of 1 or 2 (P < 0.01). The clinical success was 91% and 99% in the mGPS 0 and mGPS 1 or 2 groups, respectively (P < 0.01).
Conclusions
Although severe reflux esophagitis was more common in patients with achalasia with a high mGPS, good clinical success was obtained regardless of the preoperative mGPS.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Abbreviations
- Alb:
-
Albumin
- CRP:
-
C-reactive protein
- GPS:
-
Glasgow Prognostic Score
- LHD:
-
Laparoscopic Heller‑myotomy with Dor‑fundoplication
- mGPS:
-
Modified Glasgow Prognostic Score
- NLR:
-
Neutrophil/Lymphocyte Ratio
- PLR:
-
Platelet/Lymphocyte Ratio
- PNI:
-
Prognostic Nutritional Index
- POEM:
-
Peroral endoscopic myotomy
- TBE:
-
Timed barium esophagogram
References
Mayberry JF, Atkinson M. Epidemiology and demographics of achalasia. Gastrointest Endosc Clin N Am. 2001;11:235–48.
Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014;383:83–93.
Katada N, Sakuramoto S, Yamashita K, Shibata T, Moriya H, Kikuchi S, et al. Recent trends in the management of achalasia. Ann Thorac Cardiovasc Surg. 2022;18:420–8.
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265–71.
Costantini M, Salvador R, Capovilla G, Vallese L, Costantini A, Nicoletti L, et al. A thousand and one laparoscopic heller myotomies for esophageal achalasia: a 25-year experience at a single tertiary center. J Gastrointest Surg. 2019;23:23–35.
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.
McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534–40.
Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275–9.
Zhao C, Ding C, Xie T, Zhang T, Dai X, Wei Y. Validation and optimization of the systemic inflammation-based modified glasgow prognostic score in predicting postoperative outcome of inflammatory bowel disease: preliminary data. Sci Rep. 2018;747:1–8.
Abacioglu OO, Koyunsever NY, Kilic S, Yildirim A, Kurt IH. Glasgow prognostic score as a marker of mortality after TAVI. Braz J Cardiovasc Surg. 2021;36:796–801.
Jing X, Li C, Sun J, Peng J, Dou Y, Xu X, et al. Systemic inflammatory response markers associated with infertility and endometrioma or uterine leiomyoma in endometriosis. Ther Clin Risk Manag. 2020;11:403–12.
Serra R, Ielapi N, Licastro N, Provenzano M, Andreucci M, Bracale UM, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers for cardiovascular surgery procedures: a literature review. Rev Recent Clin Trials. 2021;16:173–9.
Hayashi J, Uchida T, Ri S, Hamasaki A, Kuroda Y, Yamashita A, et al. Clinical significance of the prognostic nutritional index in patients undergoing cardiovascular surgery. Gen Thorac Cardiovasc Surg. 2020;68:774–9.
Japan Eshophageal Society. Descriptive rules for achalasia of the esophagus, june 2012. 4th edition. Esophagus. 2017;14:275–89.
International High Resolution Manometry Working Group. The chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc. 2015;27:160–74.
Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–8.
Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364:1807–16.
Legros L, Ropert A, Brochard C, Bouguen G, Pagenault M, Siproudhis L, et al. Long-term results of pneumatic dilatation for relapsing symptoms of achalasia after heller myotomy. Neurogastroenterol Motil. 2014;26:1248–55.
Fukushima N, Masuda T, Yano F, Omura N, Tsuboi K, Hoshino M, et al. Over ten-year outcomes of laparoscopic Heller-myotomy with Dor-fundoplication with achalasia: single-center experience with annual endoscopic surveillance. Surg Endosc. 2021;12:6513–23.
de Olivaira JM, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W, et al. Timed barium swallow: a simple technique for evaluatingesophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997;169:473–9.
Tsuboi K, Omura N, Yano F, Hoshino M, Yamamoto SR, Akimoto S, et al. Impact of esophageal flexion level on the surgical outcome in patients with sigmoid esophageal achalasia. Surg Today. 2017;47:1339–46.
Lundell L, Dent J, Bennett J, Blum A, Armstrong D, Galmiche J, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.
Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med. 2011;2:95–101.
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028–30.
Hooper CE, Lyburn ID, Searle J. The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. Br J Cancer. 2015;112:1175–82.
McMillan DC, Watson WS, O’Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic infammatory response in cancer patients with weight loss. Nutr Cancer. 2001;39:210–3.
Omura N, Kashiwagi H, Tsuboi K, Ishibashi Y, Kawasaki N, Yano F, et al. Therapeutic efects of a laparoscopic Heller myotomy and Dor fundoplication of the chest pain associated with achalasia. Surg Today. 2006;36:235–40.
Glick HA, Miyazaki T, Hirano K, Gonzalez E, Jodar L, Gessner BD, et al. One-year quality of life post-pneumonia diagnosis in Japanese adults. Clin Infect Dis. 2021;15:283–90.
Tsuboi K, Yano F, Omura N, Hoshino M, Yamamoto SR, Akimoto S. Risk factors for the occurrence of peptic esophagitis following laparoscopic Heller-Dor surgery for esophageal achalasia. Dis Esophagus. 2022;35:1–10.
Omura N, Yano F, Tsuboi K, Hoshino M, Yamamoto S, Akimoto S. Surgical results of laparoscopic Toupet fundoplication for gastroesophageal reflux disease with special reference to recurrence. Esophagus. 2018;15:217–23.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statement
This study was approved by the Ethics Committee of the Jikei University School of Medicine [30-238 (9259)], and all procedures were conducted in accordance with the Helsinki Declaration.
Conflict of interest
The authors have no conflicts of interest and funding to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fukushima, N., Masuda, T., Tsuboi, K. et al. Role of modified Glasgow Prognostic Score in patients with achalasia who underwent laparoscopic Heller-myotomy with Dor-fundoplication. Esophagus (2024). https://doi.org/10.1007/s10388-024-01047-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10388-024-01047-x